This study compares brain dose metrics evaluated using multiple dedicated stereotactic radiosurgery (SRS) delivery platforms for the treatment of brain metastases.
Author profile
Minesh P. Mehta, MD
Miami Cancer Institute, Baptist Health South Florida
Occupational exposure during Lutetium-177 (Lu-177) radiopharmaceutical therapy depends on administration technique, shielding configuration, and staff proximity—temporal and spatial. This study quantified extremity and whole-body exposure contributions for va...
This study presents dosimetric results for stereotactic radiosurgery (SRS) using a self-shielded gyroscopic radiosurgery system for meningioma patients.
Efficacy, feasibility, and safety of extracranial, single-fraction MR-guided adaptive radiotherapy (SMART-1fx) was reported in the SMART ONE trial (NCT04939246). This work evaluates SMART plan quality relative to RTOG-0813 standards for an expanded cohort.
Stereotactic radiosurgery (SRS) plan optimization requires balancing high-quality dosimetry and treatment efficiency. This study compares treatment plan quality between the recently launched Zap-Axon optimizer and the Leksell Gamma Knife (GK) Lightning optimi...